Published January 12, 2022 | Version v1
Other Open

Mobilise-D: Evaluering av gange og mobilitet på en innovativ måte

  • 1. Institutt for nevromedisin og bevegelsesvitenskap, NTNU, og Klinikk for Kliniske
  • 2. Institutt for nevromedisin og bevegelsesvitenskap, NTNU, Trondheim
  • 3. Institutt for nevromedisin og bevegelsesvitenskap, NTNU, St. Olav hospital,Trondheim
  • 4. Institutt for nevromedisin og bevegelsesvitenskap, NTNU, og Avdeling for Geriatri, St. Olavs hospital, Trondheim

Description

The article describes the work done in the project with the patients in the Trondheim setup - With access to new smart body-worn digital technology it has become possible to examine mobility not only in the lab but in everyday life.

This work was supported by the Mobilise-D project that has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No. 820820. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation program and the European Federation of Pharmaceutical Industries and Associations (EFPIA). Content in this publication reflects the authors’ view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.

Files

Mobilise-D_Fysioterapeuten 4-2021 (1)-2.pdf

Files (851.4 kB)

Name Size Download all
md5:10b153835f671b8b391fc7a947edcd8b
851.4 kB Preview Download

Additional details

Funding

MOBILISE-D – Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement 820820
European Commission